Project 446722
Evaluating the additional efficacy of metabolic surgery vs optimal medical therapy in type 2 diabetes and cardiovascular disease
Evaluating the additional efficacy of metabolic surgery vs optimal medical therapy in type 2 diabetes and cardiovascular disease
Project Information
| Study Type: | Unclear |
| Research Theme: | Biomedical |
Institution & Funding
| Principal Investigator(s): | Farkouh, Michael E; Dash, Satya; Poirier, Paul; Woo, Minna N |
| Co-Investigator(s): | Abelson, Sagi; Biertho, Laurent; Billia, Filio; Dick, John E; Jackson, Timothy D; Kim, Raymond; Veit-Haibach, Patrick |
| Institution: | University Health Network (Toronto) |
| CIHR Institute: | Nutrition, Metabolism and Diabetes |
| Program: | |
| Peer Review Committee: | Team Grant: Diabetes Mechanisms and Translational Solutions - LOI |
| Competition Year: | 2020 |
| Term: | 1 yr 0 mth |
Abstract Summary
Heart disease is the leading cause of death among people with type 2 diabetes. The evidence suggests that lowering blood sugar alone is not enough to prevent heart disease. Some diabetes medications prevent heart disease, but how they do so is not known. Weight loss surgery can improve or even remit type 2 diabetes and may prevent heart disease. Here we will compare the best medical treatment to weight loss surgery to see which is better for improving type 2 diabetes and heart disease and to understand how these treatments prevent heart disease.
No special research characteristics identified
This project does not include any of the advanced research characteristics tracked in our database.